Trials / Completed
CompletedNCT04871893
Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy
Safety and Effcacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy (A Clinical Study in Patients With Combined Renal Failure and Hypercapnia Due to Acute Lung Failure in COVID-19 and Other Forms of Respiratory Insufficiency)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Fresenius Medical Care Deutschland GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objective of the study is to assess the safety and efficacy of CO2 removal by the multiECCO2R (CO2 Removal System) on the multiFiltrate/multiFiltrate Pro in veno-venous extracorporeal circulation during continuous renal replacement therapy (CRRT) in patients presenting with hypercapnia due to acute lung failure and acute kidney injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | multiECCO2R blood-gas exchanger | Treatment with the blood-gas exchanger multiECCO2R for CO2 removal |
Timeline
- Start date
- 2022-03-25
- Primary completion
- 2024-12-06
- Completion
- 2024-12-31
- First posted
- 2021-05-04
- Last updated
- 2025-02-28
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04871893. Inclusion in this directory is not an endorsement.